Home
Download Center
Case Study
pixlbio iPSC-derived intestinal organoids (pixIO) for drug metabolsim, absorption and safety assessment

pixlbio iPSC-derived intestinal organoids (pixIO) for drug metabolsim, absorption and safety assessment

Case Study
October 15, 2025
pixlbio iPSC-derived intestinal organoids (pixIO) for drug metabolsim, absorption  and safety assessment
grid

Drug-induced gastrointestinal toxicity is an underestimated adverse effect associated with a variety of symptoms ranging from asymptomatic histological changes in the gastrointestinal tissues to fatal complications. Alongside drug-induced liver injury, drug-induced gastrointestinal toxicity is a reason for drug discontinuation during drug development. However, and despite the severity of the problem, the mechanisms of drug-induced gastrointestinal toxicity are poorly understood, mainly due to the lack of relevant in vitro models able to recapitulate intestinal physiology. pixlbio intestinal organoids provide a unique in vitro system to model the human intestine. Our iPSC-derived organoids (pixIO) harbor a combination of cell types normally present in the primary intestinal epithelial in vivo, including goblet cells, Paneth cells, enterocytes, stem cells, and enteroendocrine cells. Our intestinal organoids models offer a suitable and physiologically relevant in vitro model for drug absorption and metabolism, efflux transporter studies, as well as the modeling of infectious diseases.

Download Resource
Download this resource to access the complete set of materials, insights, and supporting information related to this topic.
Other Resources

Other Resources You Might Also be Interested in